The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Javier Abel Menendez

Evanston Northwestern Healthcare Research Institute

Evanston

IL 60201

USA

[email]@enh.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Evanston Northwestern Healthcare Research Institute, Evanston, IL 60201, USA. 2004 - 2006
  • Department of Medicine, Breast Cancer Translational Research Laboratory, Evanston Northwestern Healthcare Research Institute (ENHRI), Evanston, USA. 2005 - 2006

References

  1. The antiobesity drug Orlistat induces cytotoxic effects, suppresses Her-2/neu (erbB-2) oncogene overexpression, and synergistically interacts with trastuzumab (Herceptin) in chemoresistant ovarian cancer cells. Menendez, J.A., Vellon, L., Lupu, R. Int. J. Gynecol. Cancer (2006) [Pubmed]
  2. DNA topoisomerase IIalpha (TOP2A) inhibitors up-regulate fatty acid synthase gene expression in SK-Br3 breast cancer cells: in vitro evidence for a 'functional amplicon' involving FAS, Her-2/neu and TOP2A genes. Menendez, J.A., Vellon, L., Lupu, R. Int. J. Mol. Med. (2006) [Pubmed]
  3. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity. Menendez, J.A., Vellon, L., Colomer, R., Lupu, R. Int. J. Cancer (2005) [Pubmed]
  4. Orlistat: from antiobesity drug to anticancer agent in Her-2/neu (erbB-2)-overexpressing gastrointestinal tumors?. Menendez, J.A., Vellon, L., Lupu, R. Exp. Biol. Med. (Maywood) (2005) [Pubmed]
  5. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene. Menendez, J.A., Vellon, L., Lupu, R. Ann. Oncol. (2005) [Pubmed]
  6. Exogenous supplementation with omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:6n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erbB-2) oncogene expression in human breast cancer cells. Menendez, J.A., Lupu, R., Colomer, R. Eur. J. Cancer Prev. (2005) [Pubmed]
  7. Targeting fatty acid synthase: potential for therapeutic intervention in her-2/neu-overexpressing breast cancer. Menendez, J.A., Lupu, R., Colomer, R. Drug News Perspect. (2005) [Pubmed]
  8. Effect of gamma-linolenic acid on the transcriptional activity of the Her-2/neu (erbB-2) oncogene. Menendez, J.A., Vellon, L., Colomer, R., Lupu, R. J. Natl. Cancer Inst. (2005) [Pubmed]
  9. Omega-6 polyunsaturated fatty acid gamma-linolenic acid (18:3n-6) enhances docetaxel (Taxotere) cytotoxicity in human breast carcinoma cells: Relationship to lipid peroxidation and HER-2/neu expression. Menendez, J.A., Ropero, S., Lupu, R., Colomer, R. Oncol. Rep. (2004) [Pubmed]
 
WikiGenes - Universities